Vascular disturbances in primary aldosteronism: Clinical evidence

Kidney and Blood Pressure Research

Volumn 35, Issue 6, 2013, Pages 529-533

  Widimsky Jr , J ^a   Strauch, B ^a   Petrak O ^a   Rosa, J ^a   Somloova, Z ^a   Zelinka, T ^a   Holaj, R ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Abnormalities; Blood vessels; Primary aldosteronism

Indexed keywords

ALDOSTERONE RECEPTOR; ALDOSTERONE SYNTHASE; COLLAGEN TYPE 3; EPLERENONE; MALONALDEHYDE; PROCOLLAGEN C PROTEINASE; SPIRONOLACTONE;

ADRENALECTOMY; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY RESISTANCE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CELL ACTIVATION; CELL PROLIFERATION; COMMON CAROTID ARTERY; CONSERVATIVE TREATMENT; DISEASE SEVERITY; EARLY DIAGNOSIS; ENDOTHELIAL DYSFUNCTION; FOLLOW UP; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; OXIDATIVE STRESS; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PULSE WAVE; REVASCULARIZATION; REVIEW; SODIUM INTAKE; VASCULAR SMOOTH MUSCLE; VASODILATATION; ZONA GLOMERULOSA;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; VASCULAR DISEASES; VASCULAR RESISTANCE;

EID: 84864815314     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000340031     Document Type: Review

References (41)

1. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC: High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994; 21: 315-318.
2. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF Jr: Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents J Clin Endocrinol Metab 2004; 89: 1045-1050.
3. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabrik B, Ferri C, Ganzaroli C, Giacechett G, Letizia C, Maccario M, Mallamaci F, Manelli M, Mattarelo MJ, Moretti A, Palubo C, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F: A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293-2300.
4. Funder JW, Carey RM, Fardella C, et al: Case detection, diagnosis and treatment of patients with primary aldosteronism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93: 3266-3281.
5. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P: Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002; 40: 892-896.
6. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Papadopoulos N, Vogiatzis K, Zamboulis C: Prevalence of primary hyperaldosteronism in resistant hypertension: A retrospective observational study. Lancet 2008; 371: 1921-1926.
7. Strauch B, Zelinka T, Hampl M, Bernhardt R, Widimský J: Prevalence of primary hyperaldosteronism in the Central Europe region. J Hum Hypertension 2003; 17: 349-352.
8. Rayner BL, Opie LH, Davidson JS: The aldosterone/renin ratio as a screening test for primary aldosteronism. S Afr Med J 2000; 90: 394-400.
9. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad J: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45: 1243-1248.
10. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA: Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008; 168: 80-85.
11. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Endres S, Quinkler M, Participants of the German Conn's Registry: Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: Results of the German Conn's registry. J Clin Endocrinol Metab 2009; 94: 1125-1130.
12. Nishimura M, et al: Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 1999; 33: 261-266.
13. Takeda R, Matsubara T, Miyamori I, Hatakeyama H, Morise T: Vascular complications in patients with aldosterone producing adenoma in Japan: Comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan. J Endocrinol Invest 1995; 18: 370-373.
14. Quinkler M, Born-Frontsberg E, Fourkiotis VG: Comorbidities in primary aldosteronism. Horm Metab Res 2010; 42: 429-434.
15. Rossi GP, Sacchetto A, Visentin P, Canali C, Graniero GR, Palatini P, Pessina AC: Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996; 27: 1039-1045.
16. Shigematsu Y, Hamada M, Okayama H, Hara Y, Hayashi Y, Kodama K, et al: Left ventricular hypertrophy precedes other targetorgan damage in primary aldosteronism. Hypertension 1997; 29: 723-727.
17. Muiesan ML, Salvetti M, Paini A, Agabiti-Rosei C, Monteduro C, Galbassini G, et al: Inappropriate left ventricular mass in patients with primary aldosteronism. Hypertension 2008; 52: 529-534.
18. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M, Matterello MJ, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Pessina AC, Mantero F, PAPY Study Participants: Renal damage in primary aldosteronism: Results of the PAPY Study. Hypertension 2006; 48: 232-238.
19. Stehr CB, Hellado R, Ocaranza, Carvajal CA,Mosso L, Becerra E, Solis M, Garcia L, Lavandero S, Jalil J, Fardella CE: Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients. J Hypertens 2010; 28: 2120-2126.
20. Taddei S, Virdis A, Mattei P, Salvetti A: Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993; 21: 929-933.
21. Wu VC, Lo SC, Chen YL, Huang PH, Tsai CT, Liang CJ, Kuo CC, Kuo YS, Lee BC, Wu EL, Lin YH, Sun YY, Lin SL, Chen JW, Lin SJ, Wu KD, TAIPAI Study Group: Endothelial progenitor cells in primary aldosteronism: A biomarker of severity for aldosterone vasculopathy and prognosis. J Clin Endoc Met 2011; 96: 3175-3183.
22. Rossi GP, DiBello V, Ganzarolli C, et al: Excess of aldosterone is associated with alterations of myocardial textures in primary aldosteronism. Hypertension 2002; 40: 523-526.
23. Rizzoni D, Paiardi S, Rodella L, Porteri E, De Ciuceis C, Rezzani R, Boari GE, Zani F, Miclini M, Tiberio GA, Giulini SM, Rosei CA, Bianchi R, Rosei EA: Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism. J Clin Endocrinol Metab 2006; 91: 2638-2642.
24. Holaj R, Zelinka T, Wichterle D, Petrák O, Strauch B, Widimský J Jr: Increased intimamedia thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension. J Hypertens 2007; 25: 1451-1457.
25. Bernini G, Galetta F, Franzoni F, Bardini M, Taurino C, Bernardini M, et al: Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. J Hypertens 2008; 26: 2399-2405.
26. Rossi GP, Bolognesi M, Rizzoni D, Seccia TM, Piva A, Porteri E, Tiberio GA, Giulini SM, Agabiti-Rosei E, Pessina AC: Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 2008; 51: 1366-1371.
27. Strauch B, Petrák O, Wichterle D, Zelinka T, Holaj R, Widimský J Jr: Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension. Am J Hypertens 2006; 19: 909-914.
28. Tsioufis C, Tsiachris D, Dimitriadis K, Stougiannos P, Missovoulos P, Kakkavas A, Stefanadis C, Kallikazaros I: Myocardial and aortic stiffening in the early course of primary aldosteronism. Clin Cardiol 2008; 31: 431-436.
29. Park S, Kim JB, Shim CY, Ko YG, Choi D, Jang Y, Chung N: The influence of serum aldosterone and the aldosterone/renin ratio on pulse wave velocity in hypertensive patients. J Hypertens 2007; 25: 1279-1283.
30. Wojciechowska W, Staessen JA, Stolarz K, Nawrot T, Filipovsky J, Ticha M, Bianchi G, Cwynar M, Grodzicki T, Kuznetsova T, Struiker/Boudier HA, Svobodova V, Thijs L, Van Bortel JM, Kawecka-Jaszcz K: Association of peripheral and central arterial wave reflection with CYP11B2-344C allele and sodium excretion. J Hypertens 2004; 22: 2311-2319.
31. Zelinka T, Strauch B, Pecen L, Widimský J Jr: Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome. J Hum Hypertens 2004; 18: 107-111.
32. Krug AW, Ehrhart-Bornstein M: Aldosterone and metabolic syndrome: Is increased aldosterone in metabolic syndrome patients an additional risk factor? Hypertension 2008; 51: 1252-1258.
33. Whaley-Connell A, Johnson MS, Sowers JR: Aldosterone: Role in the cardiometabolic syndrome and resistant hypertension. Prog Cardiovasc Dis 2010; 52: 401-409.
34. Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M, et al: Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 2006; 91: 454-459.
35. Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF: Fasting plasma glucose and serum lipids in patients with primary aldosteronism: A controlled cross-sectional study. Hypertension 2009; 53: 605-610.
36. Somlóová Z, Widimský J Jr, Rosa J, Wichterle D, Šrauch B, Petrák O, Zelinka T, Vlková J, Mašek M, Dvořáková J, Holaj R: The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. J Hum Hypertens 2010; 24: 625-630
37. Catena C, Colussi G, Di Fabio A, Valeri M, Marzano L, Uzzau A, Sechi LA: Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism Horm Metab Res 2010; 42: 440-445.
38. Gomez-Sanchez CE, Rossi GP, Fallo F, Mannelli M: Progress in primary aldosteronism: Present challenges and perspectives. Horm Metab Res 2010; 42: 374-381.
39. Letavernier E, Peyrard S, Amar L, Zinzindohoué F, Fiquet B, Plouin PF: Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 2008; 26: 1816-1823.
40. Lim PO, Jung RT, MacDonald TM: Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: A prospective cohort follow-up study. Br J Clin Pharmacol 1999; 48: 756-760.
41. Strauch B, Petrák O, Zelinka T, Wichterle D, Holaj R, Kasalický M, Safarík L, Rosa J, Widimský J Jr: Adrenalectomy improves arterial stiffness in primary aldosteronism. Am J Hypertens 2008; 21: 1086-1092.